Strand Life Sciences expands sequencing facility
The newly launched Genomic Health Insights (GHI) program to make sequencing accessible to all
The newly launched Genomic Health Insights (GHI) program to make sequencing accessible to all
OncoVeryx-F, a proprietary test developed by PredOmix, is set to transform early-stage cancer detection
The collaboration between CARER and Wholeleaf aims to offer an integrated approach to cancer patients, combining services and products to optimize their well-being
USFDA concludes inspection at Zydus' formulation manufacturing facility at SEZ 2, Ahmedabad
Approval to dramatically change CAR-T therapies landscape
SMPA's diverse portfolio includes six marketed products and a robust pipeline of early- to late-stage assets
India’s bioeconomy jumped from $8 billion in 2014 to $100 billion and the country now targets $150 billion by 2025
The company has submitted marketing authorization applications for mRNA-1345 with the European Medicines Agency (EMA), Swissmedic in Switzerland, and the Therapeutic Goods Administration (TGA) in Australia
Adding 20,000 liters of installed biologics drug substance manufacturing capacity
Subscribe To Our Newsletter & Stay Updated